Physician profile
Danielle Thorn
NPI 1588720098
$2,281.09
in general payments reported to CMS, 2019-2025
10 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $146 · 2022: $1,018 · 2023: $428 · 2024: $571 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.19 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eclipse Technology Solutions INC. | $989.02 | 2022 | |
| Depuy Synthes Sales INC. | $518.00 | 2021-2025 | Peak, Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $333.19 | 2023-2025 | Iovera, Zilretta, Exparel |
| Medical Device Business Services, INC. | $205.69 | 2024 | |
| Zimmer Biomet Holdings, INC. | $88.93 | 2024-2025 | Gel-One Cross-Linked Hyaluronate |
| Ferring Pharmaceuticals INC. | $60.31 | 2021-2024 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $34.00 | 2023 | Seglentis |
| Stryker Corporation | $19.36 | 2021 | |
| Exact Sciences Corporation | $18.96 | 2023 | Cologuard Collection Kit |
| Innocoll Pharmaceuticals Limited | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Thorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.